TrialPloS one2014
Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.
Michael B Bass et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it